Collagen Supplements

Collagen as a protein

A 2023 systematic review describes collagen as the main protein structure of connective tissues and puts it at about 80 percent of the dry weight of human skin. The molecule has a triple helix built from repeating units in which glycine appears at every third position, with proline and hydroxyproline in the other positions. The same review says that skin aging involves less collagen synthesis, fewer fibroblasts and fewer blood vessels in the skin, which it links to lower elasticity and the formation of wrinkles.

Growth of oral collagen products

Review authors describe a rise in the use of collagen as a supplement. A 2022 review says slowing the aging process with collagen supplements has become a driving force in dermatology and cosmetics, and the 2023 review calls hydrolyzed collagen the most popular skin anti-aging nutraceutical. A 2019 review of dermatology trials says the use of collagen for skincare was rising while information on quality, absorption and efficacy was lacking. These are descriptions by the reviewers; the sources reviewed here give no sales figures.

The sources reviewed do not give a dated origin for oral collagen or gelatin products. The clinical literature they summarize is recent: the 26 randomized trials in the 2023 skin review were published between 2014 and 2022, so the research base for beauty-oriented collagen supplements is roughly a decade old.

Names for the products

Trials and reviews use several overlapping terms. Hydrolyzed collagen, collagen hydrolysate and collagen peptides refer to collagen that has been broken into shorter chains. A 2019 dermatology review separates trials of collagen hydrolysate from smaller sets of trials of collagen tripeptide and collagen dipeptide. A 2025 review describes hydrolyzed collagen peptides in powder or liquid form as typical of food supplements and marine collagen as collagen produced from fish skin.

Gelatin is partly broken-down collagen. A Japanese study of nine adults compared ordinary gelatin, a gelatin hydrolysate and a low molecular weight gelatin hydrolysate, which shows that researchers treat these as related but distinct food materials.

Collagen types and why labels differ

Collagen comes in several types. A 2025 systematic review of musculoskeletal trials restricted itself to type I hydrolyzed collagen, while a small knee trial tested native type II collagen. A skin meta-analysis reported that different animal sources of hydrolyzed collagen did not all show the same size of effect on hydration. Findings for one product, type or source therefore cannot be carried over to another without a trial of that product.

Product forms and animal sources

Reviews describe collagen supplements as powders, liquids, capsules and gels. In the 26 randomized skin trials in the 2023 meta-analysis, 14 used fish collagen, two porcine, one bovine and one chicken collagen, and nine did not state the source. Because the sources studied are animal tissues, people who avoid animal products may wish to read the Machipedia page on Vegan Diet, and the broader page on Dietary Supplements covers how supplements are categorized in general.

Digestion and absorption

Collagen is a protein, and ingested protein is normally broken down by digestion. In a 2021 study of nine healthy adults, eating gelatin raised blood levels of the collagen-derived small peptides prolyl-hydroxyproline and hydroxyprolyl-glycine, with the first peaking about two hours and the second about one hour after eating. A low molecular weight hydrolysate raised both peptides further. The 2023 skin review adds that hydrolysates are described as easier to digest than intact proteins and cites animal tracer studies in which a labeled collagen tripeptide was later found in skin.

These findings show that collagen-derived fragments appear in blood. None of the sources reviewed shows that ingested collagen is built into human skin collagen as such, and the reviewers present effects on skin cells as proposed mechanisms. Digestion and the Machipedia page on Nutritional Therapy offer general context on how food proteins are handled.

What the sources reviewed do not cover

No source opened for this page describes bone broth as a collagen source, third-party quality testing of products, or how products are labeled. The page therefore gives no statement about those topics, and it gives no amounts or product guidance. Trial protocols vary in product, amount and duration, and the reviews themselves call for standardized protocols.

Skin appearance

The most heavily marketed and studied use is for skin that shows signs of aging. Reviews of randomized trials examine skin hydration, elasticity and wrinkles, usually measured with instruments, and some also assess the dermal matrix in biopsies. A 2019 dermatology review also lists small sets of trials in pressure ulcers, dry skin and cellulite. Whether these uses are supported is covered under Research and Evidence.

Joints, bone and muscle

Other uses studied include joint pain in osteoarthritis, bone mineral density in postmenopausal women and muscle strength in older adults, often together with resistance exercise. In bone studies, collagen is frequently taken together with calcium and vitamin D, so the Machipedia page on Vitamin D Supplementation is a relevant companion topic. Hair and nail uses are commonly advertised, but no systematic review on them was found in the searches run for this page, so the page makes no statement about them.

Skin hydration, elasticity and wrinkles

A 2021 meta-analysis of 19 randomized, double-blind, controlled trials with 1,125 participants aged 20 to 70, 95 percent of them women, reported favorable results for hydrolyzed collagen compared with placebo on hydration, elasticity and wrinkles. A 2023 meta-analysis of 26 trials with 1,721 participants found improved hydration and elasticity, noting trial durations of 2 to 12 weeks and small samples, and a 2019 review of 11 placebo-controlled trials with 805 participants reported improvements in elasticity and hydration.

A 2013 double-blind trial of 114 women aged 45 to 65 tested one branded collagen peptide product for 8 weeks and reported a reduction in eye wrinkle volume compared with placebo and higher procollagen I and elastin content in biopsies. A 2026 review of oral and topical peptides, with 19 trials and 1,341 participants, found a modest pooled effect on wrinkles, inconsistent effects on elasticity and density, and minimal adverse events. These results come from products and populations that differ, and each is specific to what was tested.

Knee osteoarthritis and joint pain

A 2019 meta-analysis of placebo-controlled trials reported a lower total WOMAC osteoarthritis score and a lower visual analog pain score with collagen, but the pain and function subscores of the WOMAC were not significantly different. A 2024 update of 11 trials with 870 participants reported improved function and pain scores favoring collagen, with high heterogeneity between trials (I-squared of 75 and 88 percent).

A small randomized trial of 39 people with knee osteoarthritis compared acetaminophen alone with acetaminophen plus native type II collagen for 3 months. Only the visual analog score for pain on walking differed between groups, and urinary markers of cartilage breakdown did not improve in either group. A 2025 systematic review of 36 trials of type I hydrolyzed collagen reported pain reduction and mobility gains in joint studies, with heterogeneity that limits generalization.

Bone and muscle

The 2025 systematic review of type I hydrolyzed collagen found that studies on bone health had limitations that prevent definitive conclusions, and that muscle studies were inconsistent, with positive effects mainly when collagen accompanied physical exercise. A 2025 meta-analysis of 20 studies, 17 of them randomized trials and mostly in postmenopausal women, reported higher bone mineral density at the femoral neck and spine, with high heterogeneity (I-squared 80.1 percent), and a muscle strength effect that came from a trial in older men with sarcopenia who also trained with resistance exercise.

Funding source and trial quality

A 2025 meta-analysis of 23 randomized trials with 1,474 participants analyzed results by funding source and study quality. When all trials were pooled, collagen improved hydration, elasticity and wrinkles. In the subgroup of trials not funded by pharmaceutical companies, no effect was found on any of the three outcomes, while trials funded by pharmaceutical companies showed significant effects, and high-quality trials showed no significant effect. The authors concluded that there is currently no clinical evidence to support collagen supplements to prevent or treat skin aging.

Other reviewers reached more favorable conclusions from the same body of trials while listing biases. The 2023 meta-analysis found risk of bias from deviations from the intended intervention in seven trials, missing outcome data in 13 and selective reporting in two. These two sets of conclusions differ and the sources reviewed do not resolve the disagreement.

Other limits of the evidence

Reviewers repeatedly note small samples, short follow-up and varied products. The 2023 review says the human studies relied on measures such as skin instruments and questionnaires and that lifestyle habits were not analyzed. The 2025 musculoskeletal review states that heterogeneity limits generalization. Author affiliations also matter for interpretation: one author of that review is listed as affiliated with a company research unit, which indicates a possible competing interest that readers can weigh but that does not itself show bias.

Participants in the skin trials were mostly women, and the bone evidence is mostly from postmenopausal women, so results may not apply to other groups. The reviews opened for this page report no long-term outcomes such as fractures or clinical joint replacement. Publication bias was not assessed in most of the reviews summarized here.

Adverse events in trials

The 2019 dermatology review reported no adverse events in the trials it covered, and a 2022 review stated that its included studies had not found adverse effects from oral collagen. A 2026 review of peptides described them as well tolerated with minimal adverse events. These statements come from trials that were mostly short, and an absence of reports in small, short trials does not show that harms do not occur.

Allergy and product quality

A 2025 dermatology review lists allergies and product quality as potential risks of collagen supplements. Because many products are made from fish, marine collagen is relevant for people with fish allergy: a 2026 allergy review identifies collagen as a minor fish allergen, clinically relevant especially in people who do not react to the main fish allergen parvalbumin. Bovine, porcine and chicken sources are also used, and the sources opened do not give frequencies of reactions.

The sources reviewed do not report contamination findings, interactions with medicines, or the results of independent product testing, and the page therefore makes no statement about them. Readers with concerns about a specific product can raise them with a pharmacist or doctor.

Care boundaries

Collagen supplements are not a replacement for assessment or treatment of joint pain, osteoporosis, skin conditions or muscle loss. The bone and muscle trials reviewed often used collagen alongside calcium, vitamin D or resistance exercise, which are separate measures. People with a known fish or animal-protein allergy, a diagnosed bone or joint condition, or other health conditions may wish to discuss supplements with a doctor or registered dietitian before use. The Machipedia page on Dietetics describes that profession, and the page on Dietary Supplements covers shared questions about supplement use.